Shenmai injection improves the postoperative immune function of papillary thyroid carcinoma patients by inhibiting differentiation into Treg cells via miR-103/GPER1 axis
Author:
Affiliation:
1. Department of thyroid surgery; The Ningbo No.2 Hospital; Ningbo People's Republic of China
Funder
Clinical research Fund of Zhejiang Medical Association
Publisher
Wiley
Subject
Drug Discovery
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/ddr.21459/fullpdf
Reference34 articles.
1. Industrial natural product chemistry for drug discovery and development;Bauer;Natural Product Reports,2014
2. Immune escape mechanisms as a guide for cancer immunotherapy;Beatty;Clinical Cancer Research,2015
3. The G protein-coupled estrogen receptor (GPER) agonist G-1 expands the regulatory T-cell population under TH17-polarizing conditions;Brunsing;Journal of Immunotherapy,2013
4. The role of microRNAs in the occurrence and development of esophageal squamous cell carcinoma;Chang;Clinical Surgery Research Communications,2017
5. Effects of combined Chinese drugs and chemotherapy in treating advanced non-small cell lung cancer;Chen;Chinese Journal of Integrative Medicine,2009
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Regulatory mechanism of GPER in the invasion and migration of ectopic endometrial stromal cells in endometriosis;Women & Health;2023-12-26
2. Shenmai injection ameliorates doxorubicin-induced myocardial injury by suppressing autophagy-apoptosis via miR-30a;Aging;2023-11-07
3. Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy;Frontiers in Immunology;2023-08-21
4. Antagonizing adipose tissue-derived exosome miR-103-hepatocyte phosphatase and tensin homolog pathway alleviates autophagy in non-alcoholic steatohepatitis: A trans-cellular crosstalk;World Journal of Gastroenterology;2023-08-07
5. Single-cell RNA sequencing reveals enhanced antitumor immunity after combined application of PD-1 inhibitor and Shenmai injection in non-small cell lung cancer;Cell Communication and Signaling;2023-07-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3